التفاصيل البيبلوغرافية
العنوان:
A decade of immune-checkpoint inhibitors in cancer therapy
المؤلفون:
Caroline Robert
المصدر:
Nature Communications Nature Communications, Vol 11, Iss 1, Pp 1-3 (2020)
بيانات النشر:
Nature Publishing Group UK, 2020.
سنة النشر:
2020
مصطلحات موضوعية:
0301 basic medicine , Oncology , medicine.medical_specialty , Science , medicine.medical_treatment , Immune checkpoint inhibitors , Programmed Cell Death 1 Receptor , Cancer therapy , General Physics and Astronomy , Cancer immunotherapy , 02 engineering and technology , Antibodies, Monoclonal, Humanized , General Biochemistry, Genetics and Molecular Biology , B7-H1 Antigen , 03 medical and health sciences , Antineoplastic Agents, Immunological , Internal medicine , Neoplasms , medicine , Humans , CTLA-4 Antigen , Clinical efficacy , lcsh:Science , Multidisciplinary , biology , business.industry , Comment , Cancer , Antibodies, Monoclonal , General Chemistry , Immunotherapy , 021001 nanoscience & nanotechnology , medicine.disease , Ipilimumab , 030104 developmental biology , Nivolumab , Toxicity , Monoclonal , biology.protein , Tumour immunology , lcsh:Q , Antibody , 0210 nano-technology , business
الوصف:
Immunotherapy using immune-checkpoint modulators revolutionizes the oncology field far beyond their remarkable clinical efficacy in some patients. It creates radical changes in the evaluation of treatment efficacy and toxicity with a more holistic vision of the patient with cancer.
اللغة:
English
تدمد:
2041-1723
الوصول الحر:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbaf2f8ae9ec128dbeaf95d89fd1c645Test http://europepmc.org/articles/PMC7393098Test
حقوق:
OPEN
رقم الانضمام:
edsair.doi.dedup.....dbaf2f8ae9ec128dbeaf95d89fd1c645
قاعدة البيانات:
OpenAIRE